BiotechTube
Home/Avotres/Yunling Ren
YR

Yunling Ren

General Counsel

Avotres

Therapeutic Areas

Autoimmune DiseasesTransplantationOncology

Avotres Pipeline

DrugIndicationPhase
AVT001Type 1 DiabetesPhase 2
AVT002Oncology (Melanoma model)Preclinical
AVT-Dx 001Autoimmune Disease DiagnosisDevelopment

Leadership Team at Avotres

HJ
Hong Jiang
Founder & Chief Scientific Officer (CSO)
AL
Alex Li
Chief Executive Officer (CEO)
HL
Harvey L. Katzeff
Chief Medical Officer (CMO)
View full Avotres profile